The implantable cardioverter-defibfillator

Clinical Cardiology

Volumn 23, Issue 5, 2000, Pages 315-326

  Greene, H Leon ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiarrhythmic drug; Cardiac arrest; Implantable cardioverter defibrillator; Sudden cardiac death; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; HEART ARREST; HEART DEATH; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; QUALITY OF LIFE; REVIEW; SURVIVAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; COST BENEFIT ANALYSIS; DRUG CONTRAINDICATION; ECONOMICS; FEMALE; MALE; MORTALITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PROGNOSIS; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0033625034     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230503     Document Type: Review

References (87)

1. Gillum RF: Sudden coronary death in the United States: 1980-1985. Circulation 1989;79:756-765
2. Graves EJ: Detailed diagnoses and procedures. National Hospital Discharge Survey, 1993. National Center for Health Statistics. 1995; Vital Health Stat 13:122
3. Graves EJ: Detailed diagnoses and procedures. National Hospital Discharge Survey, 1993. National Center for Health Statistics. 1995; Vital Health Stat 13:122
4. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias. N Engl J Med 1991;337:1576-1583
5. Mirowski M, Mower MM, Staewen WS, Denniston RH, Tabatznik B, Mendeloff AI: Standby automatic defibrillator. Arch Intern Med 1970;126:158-161
6. Schuder JC, Stoeckle H, Gold JH, West JA, Keskar PY: Experimental ventricular defibrillation with an automatic and completely implanted system. Trans Am Soc Artif Intern Organs 1970;16: 207-212
7. Schuder JC: Completely implanted defibrillator. J Am Med Assoc 1970;214:1123
8. Mirowski M, Mower MM, Gott VL, Brawley RK, Denniston R: Transvenous automatic defibrillator: Preliminary clinical tests of its defibrillating subsystem. Trans Amer Soc Artif Int Organs 1972;18: 520-525
9. Mirowski M, Mower MM, Staewen WS, Denniston RH, Mendeloff AI: The development of the transvenous automatic defibrillator. Arch Intern Med 1972;129:773-779
10. Mirowski M, Mower MM, Gott VL, Brawley RK: Feasibility and effectiveness of low-energy catheter defibrillation in man. Circulation 1973;47:79-85
11. Schuder JC, Stoeckle H, Gold JH, West JA, Holland JA: Ventricular defibrillation in the dog using implanted and partially implanted electrode systems. Am J Cardiol 1974;33:243-247
12. Langer A, Heilman MS, Mower MM, Mirowski M: Considerations in the development of the automatic implantable defibrillator. Med Instrum 1976;10:163-167
13. Mirowski M, Mower MM, Langer A, Heilman MS, Schreibman J: A chronically implanted system for automatic defibrillation in active conscious dogs: Experimental model for treatment of sudden death from ventricular fibrillation. Circulation 1978;58:90-94
14. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324
15. Lehmann MH, Saksena S: Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 1991;14:969-979
16. Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V: Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol 1991;18:1-13
17. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-1209
18. Marchlinski FE, Flores BT, Buxton AE, Hargrove WC III, Addonizio VP, Stephenson LW, Harken AH, Doherty JU, Grogan EW Jr, Josephson ME: The automatic implantable cardioverter-defibrillator: Efficacy, complications, and device failures. Ann Intern Med 1986;104:481-488
19. Akhtar M, Garan H, Lehmann MH, Troup PJ: Sudden cardiac death: Management of high-risk patients. Ann Intern Med 1991; 114:499-512
20. Bardy GH, Troutman C, Poole JE, Kudenchuk PJ, Dolack GL, Johnson G, Hofer B: Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation 1992;85: 1689-1698
21. Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D: Implantable transvenous cardioverter-defibrillators. Circulation 1993;87:1152-1168
22. Heisel A, Neuzner J, Himmrich E, Pitschner HF, Liebrich A, Jung J, Sen S: Safety of antitachycardia pacing in patients with implantable cardioverter defibrillators and severely depressed left ventricular function. Pacing Clin Electrophysiol 1995;18:137-141
23. Nasir N Jr, Pacifico A, Doyle TK, Earle NR, Hardage ML, Henry PD: Spontaneous ventricular tachycardia treated by antitachycardia pacing. Cadence Investigators. Am J Cardiol 1997;79:820-822
24. Newman D, Dorian P, Hardy J: Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993;21:1413-1418
25. Rosenqvist M: Antitachycardia pacing: Which patients and which methods? Am J Cardiol 1996;78:92-97
26. Wiethold D, Block M, Isbruch F, Bocker D, Borggrefe M, Shenasa M, Breithardt G: Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. J Am Coll Cardiol 1993;21:885-894
27. Fries R, Heisel A, Kalweit G, Jung J, Schieffer H: Antitachycardia pacing in patients with implantable cardioverter defibrillators: How many attempts are useful? Pacing Clin Electrophysiol 1997;20: 198-202
28. Bardy GH, Poole JE, Kudenchuk PJ, Dolack GL, Kelso D, Mitchell R: A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion. Circulation 1993;87:1889-1896
29. Klein LS, Miles WM, Zipes DP: Antitachycardia devices: Realities and promises. J Am Coll Cardiol 1991;18:1349-1362
30. Rankin AC, Zaim S, Powell A, Zaim B, Brooks R, McGovern BA, Garan H, Ruskin JN: Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs. Br Heart J 1993;70:61-69
31. Bardy GH, Ivey TD, Allen MD, Johnson G, Greene HL: Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systems. J Am Coll Cardiol 1989;14:165-171
32. Bardy GH, Ivey TD, Allen MD, Johnson G, Mehra R, Greene HL: A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989;14:728-733
33. Saksena S, An H, Mehra, R, DeGroot P, Krol RB, Burkhardt E, Mehta D, John T: Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304-310
34. Saksena S: Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions. Pacing Clin Electrophysiol 1993;16:202-207
35. Zipes DP, Roberts D, Pacemaker-Cardioverter-Defibrillator Investigators: Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65
36. Trappe HJ: The "modern" implantable cardioverter-defibrillator: Comparing it to those of the late 1980s. Am J Cardiol 1996;78:3-8
37. Bernstein AD, Parsonnet V: Survey of pacing and defibrillation in the United States in 1993. Am J Cardiol 1996;78:187-196
38. Reynolds DW, Naccarelli GV, Wilber DJ, The Task Force Writing Committee: NASPE Expert Consensus Statement: Physician workforce in cardiac electrophysiology and pacing. Pacing Clin Electrophysiol 1998;21:1646-1655
39. Nisam S, Mower M. ICD Trials: An extraordinary means of determining patient risk? (editorial). Pacing Clin Electrophysiol 1998; 21:1341-1346
40. Sackett DL: Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol 1993;9:487-489
41. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F: Adverse events with transvenous implantable cardioverter-defibrillators. A prospective multicenter study. Circulation 1998; 98:663-670
42. Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC: Infections of implantable cardioverter-defibrillators: Approach to management. Clin Infect Dis 1993;17:679-685
43. Hayes DL, Wang PJ, Reynolds DW, Estes M III, Griffith JL, Steffens RA, Carlo GL, Findlay GK, Johnson CM: Interference with cardiac pacemakers by cellular telephones. N Engl J Med 1997; 336:1473-1479
44. Roelke M, Bernstein AD: Cardiac pacemakers and cellular telephones (editorial). N Engl J Med 1991;316:1518-1519
45. Hayes DL, Carrillo RG, Findlay GK, Embrey M: State of the science: Pacemaker and defibrillator interference from wireless communication devices. Pacing Clin Electrophysiol 1996;19:1419-1430
46. Irnich W, Batz L, Müller R, Tobisch R: Electromagnetic interference of pacemakers by mobile phones. Pacing Clin Electrophysiol 1996;19:1431-1446
47. Mathew P, Lewis C, Neglia J, Krol RB, Saksena S: Interaction between electronic article surveillance systems and implantable defibrillators: Insights from a fourth generation ICD. Pacing Clin Electrophysiol 1997;20:2857-2859
48. McIvor ME, Reddinger J, Floden E, Sheppard RC: Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS). Pacing Clin Electrophysiol 1998;21:1847-1861
49. Harthorne JW: Theft deterrent systems: A threat for medical device recipients or an industry cat fight? Pacing Clin Electrophysiol 1998;21:1845-1846
50. Santucci PA, Haw J, Trohman RG, Pinski SL: Interference with an implantable defibrillator by an electronic antitheft-surveillance device. N Engl J Med 1998;339:1371-1374
51. Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L Jr, Stinson EB, Griffith LS, Kallman CH, Weisfeldt ML: Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585-588
52. Thomas AC, Moser SA, Smutka ML, Wilson PA: Implantable defibrillation: Eight years clinical experience. Pacing Clin Electrophysiol 1988;11:2053-2058
53. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13:1353-1361
54. Lehmann MH, Steinman RT, Schuger CD, Jackson K: The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-805
55. Lampert S, Lown B, Graboys TB, Podrid PJ, Blatt C: Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. Am J Cardiol 1988;61: 791-797
56. Hession MJ, Lampert S, Podrid PJ, Lown B: Ethmozine (moricizine HCI) therapy for complex ventricular arrhythmias. Am J Cardiol 1987;60:59F-66F
57. Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinman MM: Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989;13:442-449
58. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN: Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988;318:19-24
59. Annual post-PDA approval report on the Automatic Implantable Cardioverter Defibrillator (AICD) system: Cardiac Pacemakers Inc., February 15, 1988.
60. Newman D, Sauve MJ, Herre J, Langberg JJ, Lee MA, Titus C, Franklin J, Scheinman MM, Griffin JC: Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899-903
61. Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN: Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-1092
62. Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A, Weisfeld AC, Bakker PF, Robles-de-Medina EO: Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995;9:2195-2203
63. MADIT Executive Committee: Multicenter Automatic Defibrillator Implantation Trial (MADIT): Design and clinical protocol. Pacing Clin Electrophysiol 1991;14:920-927
64. Moss AJ, Hall WJ, Cannom DS, Daubert JR Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940
65. The AVID Investigators: Antiarrhythmics Versus Implantable Defibrillators (AVID): Rationale, design, and methods. Am J Cardiol 1995;75:470-475
66. Kim SG, Hallstrom AP, Love JC, Rosenberg Y, Powell J, Roth J, Brodsky M, Moore R, Wilkoff B: Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial and nonrandomized registry patients. Am J Cardiol 1997;80:454-457
67. Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Roy D: Canadian Implantable Defibrillator Study (CIDS): Study design and organization. Am J Cardiol 1993;72:103F-108F
68. Siebels J, Kuck K-H, CASH Investigators: Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994;127:1139-1144
69. The CABG Patch Trial Investigators and Coordinators: The Coronary Artery Bypass Graft (CABG) Patch Trial. Prog Cardiovasc Dis 1993;36:97-114
70. Bigger JT Jr for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337: 1569-1575
71. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, Simson MB, DiCarlo L, Echt DS, Packer D: Prevention of sudden death in patients with coronary artery disease: The Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis 1993;36:215-226
72. Ferguson JJ: Meeting highlights. 47th Annual Scientific Sessions of the American College of Cardiology. Circulation 1998;97: 2377-2381
73. Alexander JH, Greenbaum AB, Hudson MP, Kong DF, Miller JM, Tung CY, Whellan DJ: Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998; Electrophysiology; Session; Late-breaking Clinical Trials I. Am Heart J 1998;136:176
74. Schron EB, Friedman LM, Greene HL, Nwachuku C: Ongoing and planned clinical trials of antiarrhythmic drugs: An update. Exp Opin Invest Drugs 1998;7:427-435
75. O'Brien BJ, Buxton MJ, Rushby JA: Cost effectiveness of the implantable cardioverter defibrillator: A preliminary analysis. Br Heart J 1992;68:241-245
76. Anderson MH, Camm AJ: Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost-efficacy. Br Heart J 1993; 69:83-92
77. Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT, Ruskin JN: An analysis of the cost effectiveness of the implantable defibrillator. Circulation 1990;81:91-100
78. Larsen GC, Manolis AS, Sonnenberg FA, Beshansky JR, Estes NAM, Pauker SG: Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992;19:1323-1334
79. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA: Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126:1-12
80. Mushlin AI, Hall J, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ, MADIT Investigators: The cost-effectiveness of automatic implantable cardiac defibrillators: Results from MADIT. Circulation 1998;97:2129-2135
81. Larsen GC, McAnulty JH, Hallstrom A, Marchant C, Shein M, Akiyama T, Brodsky M, Baessler C, Pinski SL, Jennings CA, Morris M: Hospitalization charges in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial: The AVID economic study (abstr). Circulation 1997(suppl I);96:1-77
82. Kupersmith J, Hogan A, Guerrero P, Gardiner J, Mellits ED, Baumgardner B, Rovner D, Holmes-Rovner M, McLane A, Levine J: Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J 1995;130:507-515
83. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PJ, Garson A Jr, Harvey JC, Kidwell GA, Klein GJ, Levine PA, Marchlinski FE, Prystowsky EN, Wilkoff BL: Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996;94:1147-1166
84. Jung W, Anderson M, Camm AJ, Jordaens L, Petch MC, Rosenqvist M, Santini M, Luderitz B: Recommendations for driving of patients with implantable cardioverter defibrillators. Ear Heart J 1997;18:1210-1219
85. Luderitz B, Jung W, Deister A, Manz M: Patient acceptance of implantable cardioverter defibrillator devices: Changing attitudes. Am Heart J 1994;127:1179-1184
86. Jenkins LS, Steinberg JS, Kutalek SP, Cook JR, Schron EB, Friedman PL, Cross J, Bosworth-Farrel S, Roth J, Yao Q: Quality of life in patients enrolled in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial (abstr). Circulation 1997(suppl I);96:1-439
87. Namerow PB, Firth B, Heywood GM, Smith LA, Wainwright CR, Windle JR, CABG-Patch Trial Coordinators and Investigators: Health-related quality of life six months post-CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG-Patch Trial (abstr). Circulation 1997(suppl I);96:1-439